Abstract: Although a pleural effusion (PE) is a common condition in clinical practice (with a prevalence of slightly > 400 patients/100,000), a definitive diagnosis is not established in approximately 20% of cases. In the classic publications, thoracentesis provided a definitive or presumptive diagnosis in 73% of cases, although it is estimated that today this percentage could reach 95%. An undiagnosed PE is defined as one that remains of unknown origin after performing complete pleural fluid analysis (nucleated cell counts with differential diagnosis, biochemistry, culture, cytology, and flow cytometry). The aim of this paper is to review the difficulties that may be encountered when attempting to establish the cause of a PE. The reason for this diagnostic dilemma may be an atypical clinical or radiologic presentation or falsepositive or false-negative results. Furthermore, the limited frequency of some PEs is often not considered when determining the differential diagnosis.
A pleural effusion (PE) is common in clinical practice, and it is estimated that its prevalence is approximately 400 cases/ 100,000. 1 In countries such as the United States there has been an estimate of 1.3 million patients diagnosed with PE per year. 2 Despite the diagnostic tests that are currently available, up to 20% of cases remain undiagnosed. 3 In a relatively small study conducted 25 years ago, it was estimated that thoracentesis provided a definitive diagnosis in 18% of cases (Table 1 ) and a presumptive diagnosis in 55%. 4 In the remaining 27% of patients, pleural fluid analysis (PFA) was compatible with 2 or more possible diagnoses, the so-called dual diagnosis. Since that time, there has been substantial research and greater comprehension of the analysis of pleural fluid, and it is estimated that the clinician, on the basis of the clinical history, should be capable, after the initial thoracentesis, of establishing a definitive or presumptive diagnosis in approximately 95% of cases. 5 An undiagnosed PE is defined as one that remains of unknown origin following PFA after carefully reviewing the clinical presentation, blood testing, and chest imaging. The aim of this manuscript is to review the difficulties that may be encountered when attempting to establish the diagnosis of a specific disease, either because its clinical, radiologic, and PFA findings are uncommon or because of the limited frequency of some diseases (Table 1) .
INVESTIGATION OF AN UNDIAGNOSED PE
Owing to the breadth of the differential diagnosis, a systematic and exhaustive investigation must be carried out to confidently diagnose a PE ( Table 2 ). The initial diagnostic step is to determine whether the PE is a transudate (increase in hydrostatic pressure or a decrease in oncotic pressure in the pulmonary capillaries, or an increase in the negative pressure in the pleural space) or an exudate (an increase in capillary permeability, pulmonary vasculitis, or obstruction of lung lymphatic drainage). 6 Several biochemical parameters are utilized, both in pleural fluid and in blood, to make this differentiation. The most commonly used are the Light criteria [a ratio of pleural fluid protein to serum protein > 0.5; a ratio of pleural fluid lactate dehydrogenase (LDH) to serum LDH of > 0.6; or pleural fluid LDH > 2/3 of the upper limit of normal serum LDH]. It is sufficient to meet only 1 of the 3 criteria to consider the effusion as an exudate. 7 However, as these criteria are designed for the diagnosis of exudates, 8 and these changes may be observed with diuretic therapy, 9 the use of other markers has been proposed. These include, the serum-minus effusion albumin gradient (an exudate if < 1.2 g/dL) 10 or the pleural fluid cholesterol (an exudate if > 55 mg/dL), a parameter which, unlike the Light criteria, classifies transudates better, and its diagnostic usefulness has also been demonstrated. 11, 12 TRANSUDATIVE PES
Heart Failure
Congestive heart failure (CHF) is the most common cause of a pleural transudate. 13 Kataoka 14 in a prospective study of 60 patients hospitalized with heart failure demonstrated that 87% had a PE. The diagnosis is typically established on the basis of a compatible clinical presentation with the presence of cardiomegaly and bilateral or a unilateral right PE on chest radiograph. In the majority (80%) of these patients, it is not necessary to perform a diagnostic thoracentesis. 15 However, under certain circumstances, the diagnosis is problematic (Table 3 ). Contributing to this is the presence of atypical clinical symptoms (chest pain or fever) and findings on the chest radiograph, such as an absence of cardiomegaly and accentuated asymmetry in the size of the PE. Rabin and Blackman 16 in a series of 78 patients with a bilateral PE without cardiomegaly found that only 3 (3.8%) had a PE secondary to CHF after an acute myocardial infarction. The unilateral PE does not exclude heart failure. In a review of 6 series that included 783 patients with a PE due to heart failure, 125 (16%) had a right PE and 55 (7%) a left PE 17 ; in all of these situations, a thoracentesis should be performed.
The PE typically is a lymphocyte-predominant transudate. However, thoracentesis does not always resolve the diagnostic dilemma, as the Light criteria are designed to diagnose exudates; 25% of the transudates may be misclassified as exudates if the patients are receiving diuretics. 8, 9 This situation arises because if diuretics decrease pulmonary venous hypertension, the pleural fluid not only drains through the lymphatics but can be reabsorbed by the pleural capillaries. This scenario could increase the protein and LDH concentrations in the pleural fluid, so that a transudate may have the biochemical characteristics of an exudate. If the thoracentesis is delayed for several days, the results should be interpreted with caution. In this situation, a serum albumin minus pleural fluid gradient of >1.2 g/dL strongly suggests that the PE is a transudate, regardless of whether it fulfills the traditional protein and LDH criteria. 18 Eid et al 19 reviewed a series of 770 patients admitted to their hospital with a diagnosis of CHF, among whom thoracentesis was performed on 175. Of them, the PEs in 86 (49%) patients were found to be transudates and in 89 (51%) were exudates. In the latter, a cause that could justify the presence of an exudate was identified in 59 (34%) at the time of discharge, and in an additional 7 (12%) during their follow-up. Of the remaining 23 patients, 11 (48%) had been subjected to coronary artery bypass surgery 1 year prior; therefore, an exudate associated with CHF was only found in 12 (14%) patients. The authors concluded that an exudate due exclusively to CHF was uncommon, as in the majority there is another noncardiac cause. 19 Porcel et al 20 retrospectively reviewed 1312 patients with a PE; in 298 (23%) of these patients, the PEs were transudates on the basis of clinical criteria. They observed that in patients with a high number of red blood cells, >10,000 cells/mL, the specificity of the Light criteria was significantly lower than in those with lower red blood cell counts (P < 0.01). 20 They concluded that a high number of red blood cells could affect LDH levels, converting a transudate to an exudate (Table 3) .
In this context, the determination of the N-terminal probrain natriuretic peptide (NT-proBNP), a molecule secreted by the cardiac ventricles in response to their acute distension, has been proposed for the diagnosis of PE secondary to CHF. Although some studies have demonstrated its usefulness in diagnosing PEs secondary to CHF, [21] [22] [23] [24] [25] [26] [27] [28] in our experience, it is not superior to the determination of cholesterol or the Light criteria 29 (Table 4 ). These differences could be due to the sample size of the series with other factors that could alter the NT-proBNP values (such as age, gender, body mass, presence of anemia, or cardiac dysfunction) [30] [31] [32] [33] , type of patients studied, namely those with 21, 25, [27] [28] [29] or without 22, 24, 26 the presence of transudates of non-cardiac origin. The inclusion of transudates of noncardiac origin could improve the diagnostic performance of NT-proBNP, as this test can differentiate between both types of transudates, and the existence of a high percentage of exudates becomes problematic, as the NTproBNP classifies PE of cardiac origin with greater accuracy than exudates. 29 In our opinion, its inclusion among the determinations to perform in routine daily practice cannot be recommended currently, but it could be useful in those cases in which the origin of the effusion remains unknown, and there is a high suspicion that the cause is CHF.
Hepatic Hydrothorax
Hepatic hydrothorax is defined as a PE that is present in patients with liver cirrhosis and portal hypertension without an associated cardiac, pulmonary, or pleural disease. 34 It is a rare presentation of portal hypertension and usually appears in patients with ascites, 35 due to the fluid in the peritoneal cavity traversing diaphragmatic defects. 36 However, despite ultrasonography, ascites cannot be detected in 20% of cases. [37] [38] [39] The prevalence of hepatic hydrothorax varies between 4% and 6% in patients with cirrhosis, 36 with the majority being right sided (79.5%), although it can also present as a left (17.5%) or bilateral PE (3%). [39] [40] [41] [42] [43] [44] Two factors influence fluid accumulation. First, a pressure gradient between the peritoneal and the pleural space favors the unidirectional flow of ascitic fluid into the chest; and second, the diaphragmatic defects that are often observed in the tendinous portion of the right diaphragm. The latter, plus the piston effect of the liver, explains that the majority of these effusions are right sided. The fluid-forming mechanism is the same in patients without clinical ascites. 45 The PE is usually a transudate, and, rarely, the use of diuretics may result in these fluids being classified as exudates. 35 It is recommended to always perform a thoracentesis, as the PFA can exclude an associated cardiac, pulmonary, or pleural disease. Furthermore, thoracentesis is the best option for detecting the most significant complication of hepatic hydrothorax, which is spontaneous bacterial pleuritis, a bacterial infection in an existing hydrothorax, in which a parapneumonic infection has been excluded. Furthermore, 30% of patients with cirrhosis and a PE have a complicated hepatic hydrothorax, and, in agreement with existing studies, this suspicion cannot be established from the analysis of the ascitic fluid. 39 The differences between PE secondary to CHF are shown in Table 5 .
The difficulties in diagnosing a hepatic hydrothorax are summarized in Table 6 .
Nephrotic Syndrome
In nephrotic syndrome, there is an excessive loss of plasma proteins in the urine through the glomeruli, and it is diagnosed by demonstrating an excretion of total proteins > 3.5 g/d (or a total protein/creatinine ratio > 3.5); it also includes hypoalbuminemia, hypercholesterolemia, and peripheral edema. In 20% of cases, the PE is small and usually bilateral and behaves as a transudate. 46 The frequency of PF varies between 0.1% and 1%. 13, 47 The diagnosis is established in the presence of a pleural transudate, generally of prolonged presence with hypoalbuminemia and proteinuria. Llach et al 48 showed that one third of patients with nephrotic syndrome secondary to membranous or membranoproliferative glomerulonephritis had renal vein thrombosis; thus, pulmonary embolism would have to be excluded if the PE was larger than expected for nephrotic syndrome.
Urinothorax
A urinothorax is a collection of urine in the pleural space and is a rare complication of obstructive uropathy. Common causes include neoplasia, retroperitoneal fibrosis, and trauma. The majority of these patients have a urinoma in the abdominal or retroperitoneal cavity. 49 The fluid is a transudate that resembles urine and may have a characteristic odor. 50 A low pH 51 and a low glucose level 52 have been reported; these are important characteristics, as it is the only transudate in which these parameters are found to be low, with the exception of acidosis and hypoglycemia, respectively. The diagnosis is established if the pleural fluid creatinine is greater than the serum creatinine. 52 Increased levels of LDH may occur, which would erroneously classify the fluid as an exudate. 50, 53 Increased carcinoembryonic antigen values have also been reported. 50 Cerebrospinal Fluid Leak to the Pleura Exceptional cases have been described in which cerebrospinal fluid enters the pleural space as a result of a duro-pleural fistula, after penetrating trauma, or during a laminectomy. [54] [55] [56] Once the fistula is created, the cerebrospinal fluid flows from the subarachnoid space into the pleural space along a pressure gradient. The fluid is a clear transudate, with a very low protein level. The finding of b2-transferrin, a protein that is normally found only in the brain, establishes the diagnosis. 56 
Peritoneal Dialysis
The incidence of a PE in patients undergoing peritoneal dialysis is 1.6%, and can occur between 1 day and 8 years after the initiation. 57 The size of the effusion can be large enough to discontinue dialysis. The slightly positive intra-abdominal pressure that exists under normal conditions increases linearly in proportion to the volume of the dialysis fluid that is instilled. 58 The intra-abdominal volume can increase the pressure in the abdominal wall and in the support structures of the abdomen, which leads to the dialysis fluid escaping into the peritoneal cavity, and possibly across the congenital diaphragmatic defects into the pleural space. 41 The PE may be small and right sided, although it may occasionally be bilateral. Massive effusions have been described in multiparous women and always on the right side. 59 The fluid is a transudate with very high glucose levels (range, 200 to 2000 mg/dL). 60 The diagnosis is established on the basis of the presence of a transudate with very low protein levels (< 1 g/dL) and a pleural fluid/ serum glucose ratio >2, in a patient receiving peritoneal dialysis.
Trapped Lung
A trapped lung is the sequela of remote inflammation in the pleural space that results in the formation of a fibrinous membrane on the visceral pleura surface that prevents lung expansion, 61, 62 inducing an increase in negative pressure in the pleural space. The difference in hydrostatic pressures between the systemic capillaries of the parietal pleura and the pleural space is substantial and will lead to an increase in the net flow of pleural fluid into the pleural cavity until pressure equilibrium is established. The diagnosis is based on the following: (1) clinical suspicion (postthoracentesis hydropneumothorax or a PE that cannot be drained because of anterior chest pain); (2) the pleural fluid is a transudate, or protein-discordant exudate; (3) pleural manometry demonstrating a pleural space elastance > 14.5 cm H 2 O/L of fluid removed; and (4) the chest computed tomography (CT) with air contrast shows thickening of the visceral pleura. 62 A trapped lung is the end result of previous inflammation. The PFA will depend on the timing of the thoracentesis. If it was performed during a phase when the 39 CHF indicates congestive heart failure; PE, pleural effusion.
underlying disease was still active (lung in the process of becoming trapped), protein and LDH levels in the exudated range may be found in these effusions as well, although frequently the LDH may be minimally elevated. 63 
Extravascular Migration of a Central Venous Catheter
A catheter inserted into the left subclavian vein can occasionally perforate the proximal superior vena cava at the azygos recess. This may occur because of the more horizontal orientation of the left brachiocephalic vein, compared with the right side; the tip of the catheter may be of insufficient length and be positioned almost perpendicular to the superior vena cava, such that it can erode and perforate. 64 A unilateral or bilateral PE may be observed on the chest radiograph, and may be ipsilateral or contralateral to the site of the catheter insertion. The effusion volume may be small or massive depending on the time since the migration of the catheter, and it may be accompanied by a widened mediastinum. The presence of the PE and the abnormal location of the catheter tip could have been the cause for the perforation. The characteristics of the pleural fluid will depend on the fluid the patient was receiving through the central line. If it was glucose, the fluid would be a transudate with a total protein <1.0 g/dL and a pleural fluid/ serum glucose ratio >1. If the solution infused was saline or dextrose, the liquid will also be a transudate with protein levels similar to the previous scenario. However, if the patient received parenteral nutrition through the catheter, the fluid will be milky, with triglycerides >110 mg/dL, [65] [66] [67] but also with a total protein <1.0 g/dL.
Glycinothorax
Pittman and Dirnhuber 68 and Barker 69 described 2 cases of glycinothorax after a transurethral prostatectomy for resection of a bladder tumor, and glycine solution was administered to irrigate the bladder. There was perforation of the bladder wall during the operation, and the glycine entered the peritoneal cavity and subsequently into the right pleural space. The fluid of both patients was a blood-stained transudate with high levels of glycine.
Ventriculoperitoneal and Ventriculopleural Fistulas
The ventriculoperitoneal fistula is a common procedure in neurosurgical practice to shunt cerebrospinal fluid in patients with hydrocephalus. Intrathoracic complications of a ventriculoperitoneal fistula are rare, and only 8 cases of PE due to intrathoracic migration of the catheter have been reported. 70 Owing to complications that can occur with this operation, a ventriculopleural fistula is occasionally performed. The longterm results are not acceptable, as the majority become obstructed after 3 years. 71 The pleural fluid in ventriculopleural cases is cerebrospinal fluid, similar to duro-pleural fistulas, with virtually no cells and very low protein and LDH concentrations. Three cases with pleural fluid eosinophilia have been published, although 2 had peripheral eosinophilia, 72 and the other was an empyema. 73 Thus, faced with a patient with a history of a ventriculopleural fistula due to hydrocephalus and worsening of clinical symptoms, the clinician needs to consider the possibility of obstruction of the fistula, generally secondary to the accumulation of debris in the catheter or fibrous tissue that blocks the distal catheter. 74 The most important characteristics of the less common pleural transudates are summarized in Table 7 .
EXUDATIVE PES
The total nucleated cell counts in the pleural fluid usually provide useful information. Besides the nature of the pleural lesion that it produces, one of the factors that influences the cell population present is time since onset of the effusion. Thus, PEs with a predominance of neutrophils are usually observed in acute responses, whereas a predominance of lymphocytes is more common in effusions of > 2 weeks from onset. 5, 75 The clinical significance of eosinophilic PEs (eosinophil count >10% of the total nucleated cell count) is more controversial. Classically, it was believed that eosinophilic PEs were associated with a lower risk of malignancy, 76 but several studies have shown that an eosinophilic PE may not be considered as an indicator of benignancy and that its study should be the same as for any PE. [77] [78] [79] The cellular predominance of PEs are summarized in Table 8 .
Metastatic Neoplastic PEs
The neoplastic PE is one of the most common causes of a pleural exudate in the majority of series. 47, 80 The effusions that most often metastasize to the pleura are those caused by lung, breast cancer and lymphoma. 81, 82 The diagnostic yield of pleural fluid cytology is 66% and that of pleural biopsy is 46%; on combining both procedures the yield is 73%. 83 A second cytology or pleural biopsy performed a few days later can increase the diagnostic yield. 84 Several factors can explain the low yield of these procedures. If the tumor is located on the mesothelial surface, tumor cells can be observed in the pleural fluid, but if the subserous layer is invaded, fewer malignant cells enter the pleural space. 83 On other occasions, no malignant cells can be observed in the pleural fluid or biopsy because, although the lesions are due to a neoplastic disease, there is no direct pleural involvement. These effusions are termed paramalignant effusions that include: (1) the local direct effect of the tumor (lymphatic obstruction, bronchial obstruction with pneumonia, or atelectasis); (2) systemic effects of the tumor (pulmonary embolism, low plasma oncotic 85 The diagnostic yield of tumor biomarkers is questionable. In a recent meta-analysis, it appears that 2 or more markers increase the diagnostic sensitivity, provided that they are interpreted with the clinical findings and the conventional tests. 86 Porcel et al 87 studied a panel of 4 tumor markers in a PE series. 87 They established a cutoff point for each marker as no benign effusions had elevated values. The overall sensitivity was 54%, and they concluded that it may be useful for screening patients who could benefit from future invasive procedures. Similarly, Ferrer et al 88 observed that applying 4 criteria: (1) symptoms for >1 month; (2) absence of fever; (3) a bloody fluid; and (4) chest CT suggestive of neoplasia, increase the likelihood that thoracoscopy will be diagnostic. 88 Thoracoscopy continues to be the diagnostic procedure of choice for suspected malignant PEs. 89 Both pleuroscopy and video-thoracoscopy have a high sensitivity and specificity for neoplastic effusions (92.6% and 95%, respectively). 89 Bronchoscopy should be reserved for those with hemoptysis or if radiology suggests the presence of a mass or volume loss. The diagnostic yield of the tests used in the diagnosis of these individuals is summarized in Table 9 .
Malignant Pleural Mesothelioma (MPM)
An MPM should always be considered as a possibility with an undiagnosed PE, if there is a history of asbestos exposure. The diagnosis of MPM is problematic, as the exposure could have occurred years prior. The differential diagnosis by pleural biopsy between MPM, benign pleural disease induced by asbestos, and pleural metastasis due to an adenocarcinoma can be problematic, even with the use of immunohistochemistry. The sensitivities of cytology of the fluid and pleural biopsy for diagnosis are low, [90] [91] [92] [93] [94] as pleural tissue specimens, obtained by thoracoscopy 91 or thoracotomy, are required. In the past few years, efforts have been directed toward obtaining a marker in pleural fluid or blood that would be able to differentiate between the aforementioned PEs. 95 Mesothelin is expressed in normal mesothelial cells but is highly overexpressed in MPM or in cancers of the pancreas, Obstructive urinary disease with urine passing from the abdominal or retroperitoneal cavity to the pleural space due to a pressure gradient Creatinine in pleural fluid higher than in the serum 52 Transudate (sometimes an exudate due to increased levels of LDH). 53 There may be low pH 51 and glucose 52 96 Several studies have demonstrated good specificity in the diagnosis of MPMs, but with suboptimal sensitivity. [97] [98] [99] Davies et al 100 demonstrated that pleural mesothelin can help differentiate MPMs from metastatic carcinoma and benign effusions, with good reproducibility, even after pleurodesis. A relationship between serum mesothelin values and progression of disease has also been observed. 101 The diagnostic yield of the tests used in the diagnosis of MPM is summarized in Table 10 .
Tuberculous PE
A tuberculous PE is one of the most frequent causes of PE in Spain. 13 Unfortunately, the conventional methods for diagnosis have limitations, such as the minimal yield of the AFB stain and the waiting time to obtain growth of the Mycobacterium. 102, 103 However, finding necrotizing granulomas on pleural biopsy provides a much higher yield. 102 The analysis of different biochemical parameters in pleural fluid (interferon-g, ADA and its isoenzymes, lysozyme, interleukins, and lymphocyte subpopulations) [104] [105] [106] [107] [108] [109] has contributed, in some cases, to improving the diagnostic yield of tuberculous pleuritis. The determination of ADA, a reference when assessing the usefulness of new biochemical parameters in the diagnosis of tuberculous effusions, has been questioned. When finding elevated values of this parameter in young individuals who live in areas with a high incidence of tuberculosis, it is necessary to perform a pleural biopsy to establish the diagnosis. 110, 111 In a recent meta-analysis, it was estimated that the diagnostic yield of ADA was high (sensitivity 92%, specificity 90%). 112 Its combined use with the cellular predominance (lymphocyte/ neutrophil ratio Z0.75) to differentiate the pleural fluid from a parapneumonic effusion or empyema increases its sensitivity, 113 such that using a regression tree with these 2 parameters, applied to a young population (less than 40 y of age) in an area with a high tuberculosis prevalence, the diagnostic sensitivity was 99.4% and the specificity was 98.1%, without the need for a pleural biopsy. 111 The ADA-2 isoform, which is only found in macrophages, and is stimulated in the presence of live microorganisms, improves the yield of ADA. 106, 108 Other diseases can also have an increased ADA in pleural fluid 105 ; an ADA lower than the cutoff point does not exclude the diagnosis. However, it is rare to have a PE with repeatedly low ADA values to be of tuberculous origin. Ferrer et al 114 followed 40 patients with an undiagnosed PE and low ADA values for a mean of 5 years, and none of the patients developed tuberculosis. If all tests carried out were nondiagnostic, performing medical thoracoscopy may be indicated. 115 Diacon et al 116 diagnosed 100% of tuberculous effusions using this technique combined with histology and culturing. The diagnostic yield of the tests used in the diagnosis of this type of tuberculous pleuritis is summarized in Table 11 .
Parapneumonic Effusions
The diagnosis of pleural infection (parapneumonic effusion and empyema) is not problematic in its classic form. The majority (57%) of patients with pneumonia develop a PE, 117 and a small number will require chest tube drainage. 118 Several studies have shown that the incidence of pleural infections is increasing, 119, 120 and there are well-established risk factors. 121 In patients with community-acquired pneumonia, the mean time to defervescence is several days. 122 A delay in the therapeutic response tends to indicate the presence of a parapneumonic effusion or empyema. 123 PFA will confirm the presence of a pleural infection. 124 The majority of pleural infections are progressive with transformation to a complicated effusion. In the uncomplicated PE, the white cell count is low, the glucose and pH are normal, and the LDH may be elevated in patients not treated in a timely manner, and the pleural fluid may be sterile. 117 With progression of disease, the changes that occur in the pleural space include a decrease in the pH and glucose, with an increase in the LDH, 125 and the development of a complicated parapneumonic effusion. 126 Neutrophils predominate, but the white blood cell count in the pleural fluid may be variable. 127 The determination of inflammatory mediators and/or cytokines in the pleural fluid may help differentiate a complicated parapneumonic effusion from other exudates. [128] [129] [130] [131] A CT scan can help differentiate between a pleural empyema and a pulmonary abscess, 132 or between and empyema and an uncomplicated parapneumonic effusion. 133 An increase in the incidence of PEs due to atypical 134 and fungal infections has been recently reported. Ko et al 135 reported a series of 67 patients with a fungal empyema. The mortality was 73%, with a significantly higher risk of death in immunocompromised patients.
Pleural fluid cultures are positive in 58% of cases, 136,137 with a higher frequency (70%) in empyemas. 138 Blood cultures should be obtained from all patients, although the yield is low (15%), as they could be positive even when pleural fluid cultures are negative. 121 Streptococcus pneumoniae is the most frequent microorganism isolated, 139 followed by Hemophilus influenza and pyogenic bacteria, such as S. pyogenes or Staphylococcus aureus. The detection of antigens or nucleic acids 140 is indicated in the pleural fluid specimens, with a sensitivity of 80% and a specificity >90%. 141 However, the diagnosis of a pleural infection can be problematic because of the degree of pleuritis (Table 12 ). This situation can lead to a mortality that exceeds 20%, with an additional 15% of patients requiring thoracic drainage. 137, 142 In some individuals, the diagnosis may not be a parapneumonic effusion, and a diagnosis of infection may not be present (Table 13) . [143] [144] [145] [146] [147] [148] [149] 
Chylothorax and Cholesterol Effusion
When the fluid is turbid or milky, the effusion is most likely a chylothorax and less frequently a cholesterol effusion, which can be similar in appearance because of the high lipid concentration; however, these effusions have significant pathogenic differences. The first step with a fluid with this appearance is centrifugation. If the supernatant is clear, the fluid is most likely an empyema; however, if the fluid remains white and turbid, the differential is narrowed to a chylothorax or a cholesterol effusion.
A chylothorax is defined as the presence of chyle in the pleural space, which results from an obstruction in the thoracic duct, and its diagnosis is established on the basis of the analysis of the pleural fluid and the presence of chylomicrons. 150, 151 The side of the effusion depends upon the site of the obstruction. The thoracic duct follows the path of the abdominal aorta; and at the level of the fifth dorsal vertebra, the duct moves to the left. If there are no anatomic anomalies, an obstruction below this point will produce a right PE, and if above, the PE will be left sided, and possibly bilateral. 146, 152 The cholesterol effusion has a high cholesterol concentration and occurs when the pleural fluid is chronic and surrounded by fibrotic pleura with poor vascularization. 146, 153, 154 The diagnosis is not usually problematic (Table 14) , 155, 156 but the cause may be challenging. Rheumatoid arthritis and tuberculosis are the most common causes (Table 15) . Although the pleural cholesterol may be useful in differentiating transudates from exudates, 11,12 the determination of triglycerides does not appear to be useful in differentiating a transudate from an exudate. 157 
EFFUSIONS OF VASCULAR CAUSE Pulmonary Embolism
The diagnosis of a pulmonary embolism should be considered in the patient with an acute onset of chest pain and a small unilateral PE. A CT angiogram is indicated to confirm the diagnosis. 158 A PE occurs in 30% of patients with a pulmonary embolism, and typically accounts for less than a third of all hemothoraces. 159 The PE is an exudate 160, 161 with a serous appearance in 40% of cases, with a variable predominance of nucleated cells, depending on the time interval from the onset to performing the thoracentesis. 160, 161 The pleural fluid has no other distinguishable characteristics. Thoracentesis is rarely necessary in these patients. However, if the diagnosis is problematic, it would be reasonable to perform a thoracentesis if the patient is febrile or the effusion increases in volume, to exclude infection or hemothorax.
Hemothorax
The diagnosis of a hemothorax is established if the pleural fluid/blood hematocrit ratio is >50%. The most frequent causes of a hemothorax are summarized in Table 16 . The spontaneous hemopneumothorax, an accumulation of > 400 mL of blood in the pleural space and a spontaneous pneumothorax, is a rare disease that occurs in young patients and is potentially serious. It has been noted in 3% of patients with a spontaneous pneumothorax, and 33% are hemodynamically unstable when they arrive in the Emergency Department. 162 
Other Diseases of Vascular Origin
Diseases such as superior vena cava syndrome, dissection of the thoracic aorta, septic pulmonary embolism, and pulmonary venous-occlusive disease can also present with a PE. The most important characteristics for establishing the diagnosis are summarized in Table 17 . [163] [164] [165] [166] [167] 
PE IN SYSTEMIC DISEASES
Pleural disease is often a reflection of the underlying lung disease. Therefore, in systemic diseases, the PE is presumably produced by either an increase in capillary permeability resulting from existing inflammation, either in the subpleural tissue or directly involving the pleura, by direct filtration, or by an immune mechanism. Furthermore, complex reactions occur, led by the release of various proteolytic enzymes that not only affect capillary permeability but also modulate the migration of the fibroblasts, playing an important role in the extension of the pleural lesion. 168 The incidence of PEs related to systemic diseases is approximately 1%. 13, 47 Rheumatoid Arthritis
Pleural involvement is the most common intrathoracic manifestation of rheumatoid arthritis, occurring in 5% of patients. 169 Although more common in women, the majority of cases with rheumatoid arthritis-associated PE (80%) are found in middle-aged men, with an elevated rheumatoid factor, rheumatoid nodules, and high HLA-B8 and Dw3 titers. [170] [171] [172] [173] [174] The PEs are typically small, generally asymptomatic and unilateral (70%), most commonly on the left side. 175, 176 The effusions usually appear years after the diagnosis of rheumatoid arthritis and can be transient, recurrent, or chronic. 177 The fluid can be serous, milky, hemorrhagic, or purulent. The biochemical characteristics of a chronic PE (80% of cases) are typically a pH < 7.20, a glucose level < 50 mg/dL (80%), a pleural/serum glucose ratio < 0.5, an elevated LDH ( > 1000 U/L), rheumatoid titer greater than 1:320 (generally higher in the fluid than in blood), and low total hemolytic complement and complement components. However, in acute PEs, the pH and glucose levels are usually normal [177] [178] [179] ( Table 18 ). In countries with a low incidence of tuberculosis, chronic rheumatoid effusions are the most frequent cause of a cholesterol effusion, but chylothorax and empyemas have also been reported. Although the pleural biopsy is not usually diagnostic, cytology can display a specific, diagnostic pattern. 178 
Systemic Lupus Erythematosus (LE)
Pleural involvement can be the clinical presentation in 5% of cases, although between 30% and 50% will develop symptomatic pleural inflammation throughout their illness. 180 The PEs tend to be bilateral (50%), small, and are not usually accompanied by an underlying lung disease. 181, 182 They behave as typical exudates, and there are no definitive tests that differentiate lupus-associated from other effusions. 183, 184 The finding of low levels of complement and high titers of antinuclear antibodies (ANA > 1/160) are suggestive, 185, 186 but not diagnostic, as some neoplastic effusions, particularly lymphomas, can have high titers. 187 A recent study reported that the determination of ANA in pleural fluid does not provide additional information to that in serum, and its determination is only recommended in the patient with systemic erythematosus lupus and a PE of uncertain origin, as the absence of ANA in the fluid would essentially exclude the diagnosis of lupus pleuritis. 188 The presence of LE cells is highly specific, 189 although this test is rarely performed because of its long preparation time. 181 A specific immunofluorescence pattern can be observed in the pleural biopsy, characterized by the staining of the nuclei of the pleural cells, either with anti-IgM, anti-IgG, or anti-C3. 190 A PE may also be present in druginduced lupus, but typically resolves after drug withdrawal. The majority of cases of effusions due to systemic LE or druginduced lupus respond rapidly to nonsteroidal, anti-inflammatory drugs or low doses of oral corticosteroids. 180 The rest of the systemic diseases in which a PE may be present, 146 as well as their principal characteristics, are summarized in Table 19 . [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] In systemic diseases, the PE may be produced by direct infiltration of the pleura, by an immune mechanism, by renal or cardiac involvement that can accompany these conditions, as well as by the presence of a thromboembolic disease or by drugs.
Benign Asbestosis
Exposure to asbestos can produce a pleural exudate. Epler et al 203 studied a population of 1135 asymptomatic subjects who worked with materials containing asbestos. They found that 34 (3%) of this population had a benign PE, but none in the 717 who made up the control group. The prevalence varied with the exposure dose. The latency period for the appearance of the effusion is much shorter than in other diseases associated with asbestos, and, similarly, the PE due to benign asbestosis is the most frequent anomaly associated with asbestos in the first 20 years after exposure. 203, 204 The diagnostic criteria to consider a PE from asbestosis exposure are: (1) exposure to asbestos; (2) confirmation by chest radiograph or thoracentesis; (3) the absence of another disease that could cause the effusion; and (4) not having a malignant tumor in the previous 3 years. The majority of effusions are small, mainly asymptomatic (66%), and may be recurrent. 203 
Coronary Artery Bypass Graft (CABG) Surgery
CABG is one of the most common causes of a PE and appears in approximately 10% of cases. 205 Its pathogenesis is not well understood, but it is assumed that several mechanisms that are associated with time-passage since the operation may be involved. The characteristics of the fluid will depend on the etiology of the PE, and they can be transudates, exudates, hemorrhagic effusions, empyemas, or chylothorax. During the postoperative period, there are a series of circumstances such as systemic inflammatory response syndrome, a decrease in mobility, and the management of the secretions that could lead to the appearance of a PE due to heart failure, a pulmonary embolism, or a pneumonia, respectively, that are unrelated to the CABG. 206 The characteristics of PEs after CABG [207] [208] [209] [210] [211] [212] [213] [214] are summarized in Table 20 .
GASTROINTESTINAL DISEASES
A PE is occasionally produced by infradiaphragmatic disease, generally of the upper abdomen. Several mechanisms are involved in the fluid moving into the pleural space. The lymphatics that cross the diaphragm can lead to the fluid coming into contact with the abdominal side of the diaphragm reaching the pleura. If diaphragmatic tears are produced due to catheters, trauma, or surgery, the abdominal fluid may also reach the pleural space. Lastly, the vascularization of the muscular portion of the diaphragm may be instrumental in producing fluid from diseases that affect the abdominal side 
Pancreatitis
Pancreatitis is the abdominal disease that most often produces a PE. In acute pancreatitis, the inflammatory pancreatic exudate reaches the pleural space through the lymphatics, and, using CT scans, it has been observed that there may be a PE in 50% of cases. 215 In chronic pancreatitis, the PE is produced after obstruction of the pancreatic duct. In these cases, it may lead to a pancreatic-pleural fistula. In both instances (acute and chronic pancreatitis), the fluid is an exudate containing mainly polymorphonuclear cells with high amylase levels (very high if there is a fistula), although in the first phase of acute pancreatitis, the values may be normal. 216 A PE may be the first sign of a pancreatic-pleural fistula; because as a result of the decompression of the pseudocyst, many patients have few abdominal symptoms. 217 Although a PE with a high amylase content is not usually diagnostic in large series of effusions, this parameter is not as helpful in screening patients with a concomitant abdominal disease 218 and should not be determined routinely. 219 
Diseases of the Spleen
Infarctions (vascular obstruction), 220 hematomas (traumas), 221 and splenic abscesses (infections) 222 can produce small PEs, always on the left side that are biochemically exudates with a predominance of neutrophils.
Perforated Esophagus
Esophageal perforation can be traumatic (iatrogenic or spontaneous), inflammatory, or neoplastic. Iatrogenic PE (after esophageal dilation or endoscopy) are the most frequent. Spontaneous PEs (or barogenic rupture) are produced after sudden and heavy vomiting. Bladergroen et al 223 reviewed a series of 127 patients with a esophageal perforation. In 55% of cases, the rupture was iatrogenic, followed by being spontaneous (15%), and being caused by foreign bodies (14%). The esophagus was always torn longitudinally in the lower half, as the upper part has striated muscle that is less likely to rupture. Therefore, the left side is usually predominant (70% of cases). The characteristic presentation is severe, pleuritic-type, epigastric pain. If it is spontaneous, there would be a history of sudden vomiting. These patients will have fever and dysphagia, and a pneumomediastinum will be observed on chest imaging. Alcohol can be a risk in causing esophagitis. The diagnosis is established by means of an esophagogram. The fluid is an anaerobic empyema that has a very low pH (< 7.00) and a high amylase content, which can be seen with food contaminating squamous epithelial cells arising from the esophagus. 
Biliopleural Fistula
Several causes can lead to the formation of a biliopleural fistula, among which is the percutaneous biliary drain, a palliative surgical measure for obstructive jaundice that may give rise to a bilious PE. 224 Some factors that can lead to the formation of biliopleural fistula have been described: (1) complete biliary obstruction; (2) a catheter inserted between the ninth and 10th rib in the mid axillary line; and (3) prolonged drainage (7 d to 2 mo). 225 A right-sided PE is observed on the chest radiograph, at times with air-fluid levels in the liver. The fluid has a greenish appearance with the characteristics of an exudate with a predominance of polymorphonuclear cells, and a pleural fluid/serum bilirubin ratio of >1.0. Pleural complications with a percutaneous biliary drain are uncommon, but cases of hemothorax, empyema, and malignant pleural seeding have been described. 226, 227 Liver and Upper Abdomen Abscesses
Upper abdomen abscesses (liver and subphrenic) can present with a high incidence of PEs and are occasionally the first sign of the disease. 228 The effusions are usually small, sterile exudates, with a predominance of neutrophils. If the abscess ruptures in the pleural space, the fluid will be a largesized empyema.
Other Gastrointestinal Diseases
Rarely, cases of PE have been described with other gastrointestinal diseases, such as hepatitis B (exudate with a predominance of lymphocytes), 229 Epstein-Barr virus infections, 230 poorly placed enteral feeding tubes, 231 or a gastropleural fistula. 232 Table 21 summarizes the most important characteristics of the PEs secondary to a gastrointestinal disease, and Table 22 summarizes the differential diagnosis of PEs that have a low pH.
EFFUSIONS OF GYNECOLOGIC ORIGIN
A PE can also be present in a small group of gynecologic and obstetric diseases.
Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome is a serious complication of induced ovulation, which occurs 2 to 3 weeks after receiving treatment with human chorionic gonadotropin hormone, and is characterized by a massive increase in the size of the ovaries, which have multiple cysts and fluid accumulation in the third space, and causes volume depletion and hemoconcentration. 233 Currently, it is thought that ovarian hyperstimulation produces vasoactive substances [mainly interleukin 6 (IL-6) and vascular growth factor], which lead to an increase in capillary permeability, ascites, and subsequently a PE. It is also likely that other systemic factors are involved in the movement of fluid in the peritoneal and pleural cavities.
The PE appears 7 to 14 days after the injection of the hGCH, 234 usually in large volume, 235 and is on the right side (53% of cases), although it can also be bilateral (29%) 
PE in Pregnancy
Kocijancic et al 239 studied 47 pregnant women, and 28 (59.5%) had a PE, 239 compared with 25% in healthy volunteers studied by the same group. 240 If the PE is symptomatic, ovarian hyperstimulation could be a possibility.
It has been observed that pulmonary embolism is the most frequent cause of a PE in pregnant women, and the incidence of pulmonary embolism is higher in this population than in nonpregnant women. 241 Therefore, it is possible that this condition is responsible for the majority of PEs in this population.
Postpartum PE
Kochenour et al 242 described 3 women who, a few weeks postpartum, developed a clinical picture with antiphospholipid antibodies (lupus anticoagulant or anticardiolipin antibodies), pleuropulmonary disease, fever, and cardiac symptoms, in which the presence of an infection and pulmonary embolism was excluded. The authors suggested that the antiphospholipid antibodies are a risk factor for this autoimmune postpartum syndrome. They did not provide details of the fluid characteristics.
Meigs Syndrome
This syndrome consists of the presence of ascites and PE in patients with a benign ovarian tumor (fibroma), which disappear after removal of the tumor. 243 It was subsequently observed that in pelvic tumors of another nature (benign tumors of the uterus, low-grade malignant ovarian tumors with no evidence of metastasis, and endometriomas) the ascites and the PE also resolved after extirpation of the tumor. The importance of this syndrome is that not all patients with a pelvic mass, ascites, and PE have metastatic disease. It appears that these primary tumors produce a large volume of fluid that reaches the peritoneal cavity (ascites) and, through the diaphragm, arrives in the pleural space. The ascites and the pleural fluid have the same characteristics, and the PE rapidly reappears after thoracentesis. In 70% of cases, the PE is on the right, on the left in 10%, and bilateral in 20%. 244 The fluid usually behaves as an exudate 245 (although its clear appearance may lead to thinking that it is a transudate), and increased values of CA-125 have occasionally been reported without indicating the presence of a neoplasm. 246 
Endometriosis and PE
Cases of severe endometriosis have been described that are complicated with ascites and occasionally a PE. 247, 248 The frequency is relatively low, as only 13 cases were reported in a recent review. 249 The mechanism by which the fluid reaches the pleural space is the same as in Meigs syndrome. The symptoms are pain and abdominal distension, nausea, and weight loss. There may also be dysmenorrhea, and sometimes the symptoms increase with menstrual periods. The PE is usually right sided, bloody, and may have a chocolate-brown 
Catamenial Hemothorax
Catamenial hemothorax or thoracic endometriosis is an uncommon condition, with only a few cases described. Shepard et al 250 reviewed the characteristics of 16 cases with this condition. All hemothoraces were on the right, and occurred in nulliparous women in the fourth decade of life; they had known pelvic and peritoneal endometriosis and, characteristically, had abdominal pain after starting menstruation. Dyspnea was a common symptom. 250 The fluid is bloody and is an exudate. 250 The most important characteristics of the PEs of gynecologic origin are summarized in Table 23 .
LYMPHATIC CHANGES
In lymphangioleiomyomatosis and yellow nail syndrome, there are changes in the lymphatic vessels, and the PE is produced because the fluid is not able to be reabsorbed due to lymphatic obstruction.
Lymphangioleiomyomatosis
It is a disease of unknown origin that affects women of child-bearing age and is characterized by the proliferation and infiltration of atypical smooth muscle cells in all the lung structures (airways, blood vessels, lymphatic, and interstitial cells). 251, 252 Respiratory failure is progressive, and the appearance of pleural complications (pneumothorax and chylothorax) suggests the clinician to consider the diagnosis of this disease. Chylothorax is less frequent than pneumothorax in lymphangioleiomyomatosis, with a prevalence of 20% to 30% in all of the published series. 253 Its pathogenesis is lymphatic obstruction by the smooth muscle cells, and there can also be abdominal involvement with chylous ascites and enlarged lymph nodes. 254, 255 They are usually unilateral effusions (of any side), large, and rarely occur simultaneously with a pneumothorax.
Yellow Nail Syndrome
The triad of symptoms consists of the presence of deformed yellow nails, lymphedema, and a PE. 256 The lymphatic dysfunction (the origin of the disease) causes disfiguration, thickening and yellowing of the nails, lymphedema, and a PE generated by impaired lymphatic drainage. This syndrome may be secondary to several diseases, and all symptoms do not have to be present simultaneously. The amount of fluid varies between small and massive. The fluid is bilateral in 50% of cases. The fluid is an exudate with a predominance of lymphocytes, with a tendency to recur after thoracentesis. 257 In rare cases, the fluid can be a chylothorax.
Uremia
Approximately 50% of patients on long-term hemodialysis develop a PE, 258 although there is no relationship with the grade of the uremia. 259 More than half are symptomatic (fever, chest pain, cough, and dyspnea). 259 The pleural fluid is an exudate with a predominance of lymphocytes. The diagnosis is established as an undiagnosed PE with changes in renal function.
PE Due to Drugs
With an undiagnosed PE, it is important to obtain a detailed clinical history focused on the prior treatment with drugs. Although uncommon, a large variety of drugs can produce a pleural exudate. 60 However, the drugs on which 100 or more cases have been described are much less numerous (methotrexate, amiodarone, phenytoin, nitrofurantoin, and bblockers). 190, 260 More detailed information can be found at http://www.pneumotox.com. 
